+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tu1388 Subjects With Irritable Bowel Syndrome-Constipation are More Constipated Than Those With Chronic Constipation: Spectrum From a Population Based Study



Tu1388 Subjects With Irritable Bowel Syndrome-Constipation are More Constipated Than Those With Chronic Constipation: Spectrum From a Population Based Study



Gastroenterology 142(5): S-818-S-819




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 064260425

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(12)63182-5


Related references

Su1040 Longitudinal Direct Medical Costs Associated With Irritable Bowel Syndrome-Constipation and Chronic Idiopathic Constipation in a Population-Based Sample Over a 10-Year Period. Gastroenterology 144(5): S-383, 2013

Sa1065 Irritable Bowel Syndrome With Constipation (IBS-C), Chronic Idiopathic Constipation (CIC), Functional Dyspepsia (FD), and Gastroesophageal Reflux Disease (GERD) Commonly Overlap: Results of a Cross-Sectional Population-Based Survey. Gastroenterology 146(5): S-189-S-190, 2014

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Alimentary Pharmacology and Therapeutics 41(9): 856-866, 2015

The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population. Journal of Medical Economics 17(8): 577-586, 2014

Sa2010 Differentiation of Functional Constipation (Fc) and Irritable Bowel Syndrome-Constipation Predominant (Ibs-C) Based on Rome Iii Criteria. A Population Based Study. Gastroenterology 146(5): S-354, 2014

A case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort. Journal of Medical Economics 20(3): 273-279, 2017

Tu2064 ROME III Functional Constipation (FC) and Irritable Bowel Syndrome - Constipation Predominant (IBS-C) - Truly Distinct Disorders or One Disease Spectrum?. Gastroenterology 144(5): S-917-S-918, 2013

Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology 145(4): 749, 2013

Prucalopride accelerates small bowel and colonic transit in patients with chronic functional constipation or constipation-predominant irritable bowel syndrome. Gastroenterology 118(4 Suppl 2 Part 1): AGA A845, 2000

Plecanatide (Trulance) for Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation. P and T 43(4): 207-232, 2018

Diagnosis, treatment, and management of irritable bowel syndrome with constipation and chronic constipation. Medgenmed 7(3): 71, 2005

Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation. United European Gastroenterology Journal 1(1): 7, 2013

Linaclotide: a novel therapy for chronic constipation and constipation-predominant irritable bowel syndrome. Gastroenterology and Hepatology 8(10): 653-660, 2012

New treatment option for irritable bowel syndrome with constipation and chronic idiopathic constipation. Gastroenterology and Hepatology 8(12): 825-828, 2012

Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Canadian Journal of Gastroenterology 21 Suppl B: 3b, 2007